{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:29:15Z","timestamp":1793035755232,"version":"4.5.0"},"reference-count":131,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    <jats:italic>Candida auris<\/jats:italic>\n                    is an invasive fungal pathogen recognized globally as a significant health threat due to its marked resistance to multiple classes of antifungal agents, including azoles, echinocandins, and polyenes. The associated high morbidity and mortality rates present considerable public health challenges. Research efforts have largely focused on understanding the molecular mechanisms of antifungal resistance and developing alternative therapies to counteract this issue. This review summarizes current advances in the identification of natural antifungal compounds, the development of novel synthetic agents, biological antifungals, nanotechnology-based approaches, combination therapies, and photodynamic treatments. Notably, several synthetic compounds such as rezafungin and fosmanogepix are in clinical trials for\n                    <jats:italic>C. auris<\/jats:italic>\n                    infections. Biological antifungals, including monoclonal antibodies, vaccines, and peptides, have shown the capacity to enhance host immune responses and reduce mortality in murine models. Combination therapies have proven particularly valuable for overcoming resistance by exploiting synergistic effects and broadening antimicrobial coverage. Despite these promising developments, majority of studies have been conducted\n                    <jats:italic>in vitro<\/jats:italic>\n                    , with a relative lack of\n                    <jats:italic>in vivo<\/jats:italic>\n                    or human research. Therefore, further investigation is needed to validate the efficacy and safety of these alternative antifungal strategies for the treatment of drug-resistant\n                    <jats:italic>C. auris<\/jats:italic>\n                    infections.\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2025.1641373","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T05:38:10Z","timestamp":1753940290000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Innovative antifungal strategies to combat drug-resistant Candida auris: recent advances and clinical implications"],"prefix":"10.3389","volume":"15","author":[{"given":"Wei","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3201\/eid2410.180649","article-title":"Candida auris in healthcare facilities, new york, USA 2013-2017","volume":"24","author":"Adams","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1128\/AAC.44.10.2900-2902.2000","article-title":"A pharmacokinetic study of amphotericin B lipid complex injection (Abelcet) in patients with definite or probable systemic fungal infections","volume":"44","author":"Adedoyin","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3390\/pharmaceutics15051365","article-title":"In Vitro Killing Activities of Anidulafungin and Micafungin with and without Nikkomycin Z against Four Candida auris Clades","volume":"15","author":"Adnan","year":"2023","journal-title":"Pharmaceutics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e0047923","DOI":"10.1128\/mbio.00479-23","article-title":"Small molecules restore azole activity against drug-tolerant and drug-resistant Candida isolates","volume":"14","author":"Alabi","year":"2023","journal-title":"mBio"},{"key":"B5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3390\/jof8070744","article-title":"Silver Nanoparticles: A Promising Antifungal Agent against the Growth and Biofilm Formation of the Emergent Candida auris","volume":"8","author":"AlJindan","year":"2022","journal-title":"J. Fungi (Basel)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.713092","article-title":"Photodynamic therapy is effective against candida auris biofilms","volume":"11","author":"Bapat","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/jac\/dkab052","article-title":"Antifungal activity of nikkomycin Z against Candida auris","volume":"76","author":"Bentz","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/microorganisms13030652","article-title":"Candida auris: A continuing threat","volume":"13","author":"Bhargava","year":"2025","journal-title":"Microorganisms"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01393-19","article-title":"In vitro antifungal combination of flucytosine with amphotericin B, voriconazole, or micafungin against Candida auris shows no antagonism","volume":"63","author":"Bidaud","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"ii3","DOI":"10.1093\/jac\/dkac351","article-title":"Liposomal amphotericin B-the past","volume":"77","author":"Bruggemann","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1080\/22221751.2022.2034485","article-title":"Resistance profiling of Aspergillus fumigatus to olorofim indicates absence of intrinsic resistance and unveils the molecular mechanisms of acquired olorofim resistance","volume":"11","author":"Buil","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e00690","DOI":"10.1002\/prp2.690","article-title":"Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent","volume":"9","author":"Cass","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0057024","DOI":"10.1128\/aac.00570-24","article-title":"Recent increase in Candida auris frequency in the SENTRY surveillance program: antifungal activity and genotypic characterization","volume":"68","author":"Castanheira","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"B14","unstructured":"Antifungal Susceptibility Testing for C. auris\n          \n          2024"},{"key":"B15","unstructured":"Antimicrobial Resistance Facts and Stats\n          \n          2025"},{"key":"B16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00134-014-3603-2","article-title":"Incidence, characteristics and outcome of ICU-acquired candidemia in India","volume":"41","author":"Chakrabarti","year":"2015","journal-title":"Intensive Care Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e375","DOI":"10.1016\/S1473-3099(21)00203-6","article-title":"Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM","volume":"21","author":"Chen","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1146\/annurev-micro-032521-015858","article-title":"Candida auris genetics and emergence","volume":"77","author":"Chowdhary","year":"2023","journal-title":"Annu. Rev. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1007\/s11274-012-1042-1","article-title":"Resveratrol lacks antifungal activity against Candida albicans","volume":"28","author":"Collado-Gonzalez","year":"2012","journal-title":"World J. Microbiol. Biotechnol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02280-16","article-title":"In vitro and in vivo antifungal profile of a novel and long-acting inhaled azole, PC945, on aspergillus fumigatus infection","volume":"61","author":"Colley","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM","volume":"25","author":"Cornely","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40560-018-0342-4","article-title":"Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris","volume":"6","author":"Cortegiani","year":"2018","journal-title":"J. Intensive Care"},{"key":"B23","doi-asserted-by":"publisher","first-page":"5710","DOI":"10.1128\/AAC.05404-11","article-title":"Blue dye and red light, a dynamic combination for prophylaxis and treatment of cutaneous Candida albicans infections in mice","volume":"55","author":"Dai","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1504866","article-title":"Nineteen years retrospective analysis of epidemiology, antifungal resistance and a nomogram model for 30-day mortality in nosocomial candidemia patients","volume":"15","author":"Dai","year":"2025","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11274-024-04223-4","article-title":"Inhibitory effects of berberine on fungal growth, biofilm formation, virulence, and drug resistance as an antifungal drug and adjuvant with prospects for future applications","volume":"41","author":"Ding","year":"2024","journal-title":"World J. Microbiol. Biotechnol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/cbdd.13827","article-title":"Synergistic antifungal effects of curcumin derivatives as fungal biofilm inhibitors with fluconazole","volume":"97","author":"Dong","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"B27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev-med-061523-021233","article-title":"Candida auris: epidemiology and antifungal strategy","volume":"76","author":"Eix","year":"2025","journal-title":"Annu. Rev. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ijantimicag.2018.08.016","article-title":"Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris","volume":"52","author":"Eldesouky","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/jof10050362","article-title":"A Mini-Review of In Vitro Data for Candida Species, Including C. auris, Isolated during Clinical Trials of Three New Antifungals: Fosmanogepix, Ibrexafungerp, and Rezafungin","volume":"10","author":"Espinel-Ingroff","year":"2024","journal-title":"J. Fungi (Basel)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091823","article-title":"Orally administered amphotericin B nanoformulations: physical properties of nanoparticle carriers on bioavailability and clinical relevance","volume":"14","author":"Fairuz","year":"2022","journal-title":"Pharmaceutics"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01056-17","article-title":"In Vitro Interactions of Echinocandins with Triazoles against Multidrug-Resistant Candida auris","volume":"61","author":"Fakhim","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2025.107041","article-title":"Extracellular fungal Hsp90 represents a promising therapeutic target for combating fungal infections","volume":"207","author":"Fang","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1007\/s13346-024-01749-w","article-title":"Nanoparticles in the battle against Candida auris biofilms: current advances and future prospects","volume":"15","author":"Fayed","year":"2024","journal-title":"Drug Delivery Transl. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/mmy\/myab059","article-title":"Caspofungin-resistance in Candida auris is cell wall-dependent phenotype and potential prevention by zinc oxide nanoparticles","volume":"59","author":"Fayed","year":"2021","journal-title":"Med. Mycol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1339501","article-title":"Promising immunotherapeutic targets for treating candidiasis","volume":"14","author":"Feng","year":"2024","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00105","article-title":"Antifungal peptides as therapeutic agents","volume":"10","author":"Fernandez de Ullivarri","year":"2020","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/mmy\/myy054","article-title":"Candida auris: The recent emergence of a multidrug-resistant fungal pathogen","volume":"57","author":"Forsberg","year":"2019","journal-title":"Med. Mycol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.1038\/s41467-021-26850-3","article-title":"Leveraging machine learning essentiality predictions and chemogenomic interactions to identify antifungal targets","volume":"12","author":"Fu","year":"2021","journal-title":"Nat. Commun."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/jof9080800","article-title":"Anti-candidal marine natural products: A review","volume":"9","author":"Ganeshkumar","year":"2023","journal-title":"J. Fungi (Basel)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/jof10060408","article-title":"Current perspectives of antifungal therapy: A special focus on candida auris","volume":"10","author":"Ganeshkumar","year":"2024","journal-title":"J. Fungi (Basel)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/jof6040262","article-title":"Rezafungin-mechanisms of action, susceptibility and resistance: similarities and differences with the other echinocandins","volume":"6","author":"Garcia-Effron","year":"2020","journal-title":"J. Fungi (Basel)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9120898","article-title":"Candida auris urinary tract infections and possible treatment","volume":"9","author":"Griffith","year":"2020","journal-title":"Antibiot. (Basel)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1007\/s00253-023-12714-x","article-title":"Biochemical and metabolomic insights into antifungal mechanism of berberine against Candida glabrata","volume":"107","author":"Gupta","year":"2023","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1008527","article-title":"Genome-wide scan for potential CD4+ T-cell vaccine candidates in Candida auris by exploiting reverse vaccinology and evolutionary information","volume":"9","author":"Gupta","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jiac.2021.09.018","article-title":"Activity of chlorhexidine acetate in combination with fluconazole against suspensions and biofilms of Candida auris","volume":"28","author":"Hao","year":"2022","journal-title":"J. Infect. Chemother."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13226675","article-title":"Candida auris: epidemiology update and a review of strategies to prevent spread","volume":"13","author":"Hayes","year":"2024","journal-title":"J. Clin. Med."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02438-19","article-title":"Rezafungin In Vitro Activity against Contemporary Nordic Clinical Candida Isolates and Candida auris Determined by the EUCAST Reference Method","volume":"64","author":"Helleberg","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s40265-021-01611-0","article-title":"The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin","volume":"81","author":"Hoenigl","year":"2021","journal-title":"Drugs"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2024.2413329","article-title":"Alkaloids solenopsins from fire ants display in vitro and in vivo activity against the yeast Candida auris","volume":"15","author":"Honorato","year":"2024","journal-title":"Virulence"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1021\/np5002576","article-title":"Antifungal activity of resveratrol derivatives against Candida species","volume":"77","author":"Houille","year":"2014","journal-title":"J. Nat. Prod."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e0018924","DOI":"10.1128\/msphere.00189-24","article-title":"Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis","volume":"9","author":"Huang","year":"2024","journal-title":"mSphere"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001542","article-title":"Antifungal activity and potential mechanism of berberine hydrochloride against fluconazole-resistant Candida albicans","volume":"71","author":"Huang","year":"2022","journal-title":"J. Med. Microbiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e0005322","DOI":"10.1128\/aac.00053-22","article-title":"Candida auris pan-drug-resistant to four classes of antifungal agents","volume":"66","author":"Jacobs","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"B54","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/apm.13336","article-title":"Azole resistance in Candida auris: mechanisms and combinatorial therapy","volume":"131","author":"Jangir","year":"2023","journal-title":"APMIS"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2406065","article-title":"Dual-antigen fusion protein vaccination induces protective immunity against Candida albicans infection in mice","volume":"20","author":"Jia","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00833-17","article-title":"De Novo Acquisition of Resistance to SCY-078 in Candida glabrata Involves FKS Mutations That both Overlap and Are Distinct from Those Conferring Echinocandin Resistance","volume":"61","author":"Jimenez-Ortigosa","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e0164522","DOI":"10.1128\/aac.01645-22","article-title":"Heightened Efficacy of Anidulafungin When Used in Combination with Manogepix or 5-Flucytosine against Candida auris In Vitro","volume":"67","author":"John","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"B58","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/BF02977758","article-title":"Fungicidal effect of resveratrol on human infectious fungi","volume":"28","author":"Jung","year":"2005","journal-title":"Arch. Pharm. Res."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11111658","article-title":"Advancing vaccine strategies against candida infections: exploring new frontiers","volume":"11","author":"Kaur","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/jam.12289","article-title":"Anti-biofilm forming and anti-quorum sensing activity of selected essential oils and their main components on food-related micro-organisms","volume":"115","author":"Kerekes","year":"2013","journal-title":"J. Appl. Microbiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"7240","DOI":"10.1038\/s41598-025-92100-x","article-title":"An 11-Year retrospective analysis of candidiasis epidemiology, risk factors, and antifungal susceptibility in a tertiary care hospital in China","volume":"15","author":"Khan","year":"2025","journal-title":"Sci. Rep."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/jac\/dkac062","article-title":"Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim","volume":"77","author":"Kirchhoff","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"B63","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ijbiomac.2022.12.139","article-title":"A pH-tuned chitosan-PLGA nanocarrier for fluconazole delivery reduces toxicity and improves efficacy against resistant Candida","volume":"227","author":"Kolge","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020771","article-title":"The Neosartorya fischeri Antifungal Protein 2 (NFAP2): A New Potential Weapon against Multidrug-Resistant Candida auris Biofilms","volume":"22","author":"Kovacs","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.cmi.2024.03.006","article-title":"New treatment options for critically important WHO fungal priority pathogens","volume":"31","author":"Kriegl","year":"2024","journal-title":"Clin. Microbiol. Infect."},{"key":"B66","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1128\/JCM.00319-11","article-title":"First three reported cases of nosocomial fungemia caused by Candida auris","volume":"49","author":"Lee","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10101303","article-title":"Nanomaterial-based antifungal therapies to combat fungal diseases aspergillosis, coccidioidomycosis, mucormycosis, and candidiasis","volume":"10","author":"Leon-Buitimea","year":"2021","journal-title":"Pathogens"},{"key":"B68","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/21505594.2016.1188235","article-title":"Exploiting mitochondria as targets for the development of new antifungals","volume":"8","author":"Li","year":"2017","journal-title":"Virulence"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02573","article-title":"Fungal cell wall: emerging antifungals and drug resistance","volume":"10","author":"Lima","year":"2019","journal-title":"Front. Microbiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11274-025-04255-4","article-title":"Exploring the antivirulence potential of phenolic compounds to inhibit quorum sensing in Pseudomonas aeruginosa","volume":"41","author":"Lima","year":"2025","journal-title":"World J. Microbiol. Biotechnol."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100887","article-title":"Cage-modified hypocrellin against multidrug-resistant Candida spp. with unprecedented activity in light-triggered combinational photodynamic therapy","volume":"65","author":"Liu","year":"2022","journal-title":"Drug Resist. Update"},{"key":"B72","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/08927014.2020.1759559","article-title":"Antifungal evaluation of traditional herbal monomers and their potential for inducing cell wall remodeling in Candida albicans and Candida auris","volume":"36","author":"Liu","year":"2020","journal-title":"Biofouling"},{"key":"B73","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11908-022-00782-5","article-title":"Antifungal resistance and the role of new therapeutic agents","volume":"24","author":"Logan","year":"2022","journal-title":"Curr. Infect. Dis. Rep."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17010116","article-title":"Amphotericin B encapsulation in polymeric nanoparticles: toxicity insights via cells and zebrafish embryo testing","volume":"17","author":"Maciel-Magalhaes","year":"2025","journal-title":"Pharmaceutics"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/diseases13040093","article-title":"A comprehensive review of candidemia and invasive candidiasis in adults: focus on the emerging multidrug-resistant fungus candida auris","volume":"13","author":"Mallick","year":"2025","journal-title":"Diseases"},{"key":"B76","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1080\/1040841X.2017.1295225","article-title":"Antimicrobial activity of eugenol and essential oils containing eugenol: A mechanistic viewpoint","volume":"43","author":"Marchese","year":"2017","journal-title":"Crit. Rev. Microbiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17425247.2024.2421402","article-title":"Improving antifungal lipid-based drug delivery against Candida: a review","volume":"12","author":"Marena","year":"2024","journal-title":"Expert Opin. Drug Delivery"},{"key":"B78","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1128\/AAC.00291-11","article-title":"In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds","volume":"55","author":"Miyazaki","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/186864","article-title":"A review on antibacterial, antiviral, and antifungal activity of curcumin","volume":"2014","author":"Moghadamtousi","year":"2014","journal-title":"BioMed. Res. Int."},{"key":"B80","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/myc.12647","article-title":"The first cases of Candida auris candidaemia in Oman","volume":"60","author":"Mohsin","year":"2017","journal-title":"Mycoses"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/mmy\/myab032","article-title":"In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms","volume":"59","author":"Nagy","year":"2021","journal-title":"Med. Mycol."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02195-19","article-title":"In Vitro Evaluation of Antifungal Drug Combinations against Multidrug-Resistant Candida auris Isolates from New York Outbreak","volume":"64","author":"O\u2019Brien","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B83","doi-asserted-by":"publisher","first-page":"942","DOI":"10.4014\/jmb.0911.11014","article-title":"Resveratrol impaired the morphological transition of Candida albicans under various hyphae-inducing conditions","volume":"20","author":"Okamoto-Shibayama","year":"2010","journal-title":"J. Microbiol. Biotechnol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1128\/AAC.00870-07","article-title":"Comparison of the physicochemical, antifungal, and toxic properties of two liposomal amphotericin B products","volume":"52","author":"Olson","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B85","doi-asserted-by":"publisher","first-page":"6872","DOI":"10.1128\/AAC.00701-16","article-title":"Preclinical evaluation of the stability, safety, and efficacy of CD101, a novel echinocandin","volume":"60","author":"Ong","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B86","doi-asserted-by":"publisher","first-page":"6","DOI":"10.15585\/mmwr.mm6901a2","article-title":"Candida auris isolates resistant to three classes of antifungal medications - new yor","volume":"69","author":"Ostrowsky","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1086\/503428","article-title":"A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis","volume":"42","author":"Pachl","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3201\/eid2503.180927","article-title":"Management of Patients with Candida auris Fungemia at Community Hospital, Brooklyn, New York, USA 2016-2018(1)","volume":"25","author":"Park","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01872-17","article-title":"Fluconazole-resistant candida auris is susceptible to salivary histatin 5 killing and to intrinsic host defenses","volume":"62","author":"Pathirana","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169264","article-title":"Antimicrobial peptides with anti-candida activity","volume":"23","author":"Perez-Rodriguez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02031-20","article-title":"Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program","volume":"65","author":"Pfaller","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3390\/jof8080771","article-title":"Initial Results of the International Efforts in Screening New Agents against Candida auris","volume":"8","author":"Poester","year":"2022","journal-title":"J. Fungi (Basel)"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3390\/jof8020204","article-title":"Antifungal activity of human cathelicidin LL-37, a membrane disrupting peptide, by triggering oxidative stress and cell cycle arrest in candida auris","volume":"8","author":"Rather","year":"2022","journal-title":"J. Fungi (Basel)"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgac248","article-title":"Immunogenicity and protective efficacy of a pan-fungal vaccine in preclinical models of aspergillosis, candidiasis, and pneumocystosis","volume":"1","author":"Rayens","year":"2022","journal-title":"PNAS Nexus"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6007607","article-title":"Candida auris Invasive Infection after Kidney Transplantation","volume":"2022","author":"Reque","year":"2022","journal-title":"Case Rep. Nephrol."},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22116162","article-title":"Candida Cell-Surface-Specific Monoclonal Antibodies Protect Mice against Candida auris Invasive Infection","volume":"22","author":"Rosario-Colon","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112459","article-title":"Monoclonal antibodies targeting Candida disrupt biofilms and inhibit growth across global clinical isolates","volume":"28","author":"Rosario-Colon","year":"2025","journal-title":"iScience"},{"key":"B99","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/myc.12781","article-title":"An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital","volume":"61","author":"Ruiz-Gaitan","year":"2018","journal-title":"Mycoses"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106906","article-title":"Lopinavir and ritonavir act synergistically with azoles against Candida auris in vitro and in a mouse model of disseminated candidiasis","volume":"62","author":"Salama","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e0055624","DOI":"10.1128\/aac.00556-24","article-title":"Overcoming amphotericin B resistance in Candida auris using the antiemetic drug rolapitant","volume":"68","author":"Salama","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"B102","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1348-0421.2008.00083.x","article-title":"Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital","volume":"53","author":"Satoh","year":"2009","journal-title":"Microbiol. Immunol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/mmy\/myz112","article-title":"Comparison of risk factors and outcomes of Candida auris candidemia with non-Candida auris candidemia: A retrospective study from Pakistan","volume":"58","author":"Sayeed","year":"2020","journal-title":"Med. Mycol."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.136555","article-title":"Novel nanoformulation for enhanced amphotericin B efficacy and sustained release using vetiver root cellulose nanofibers against Candida albicans","volume":"282","author":"Seth","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001835","article-title":"Antifungal activity of human antimicrobial peptides targeting apoptosis in Candida auris","volume":"73","author":"Shaban","year":"2024","journal-title":"J. Med. Microbiol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jcrc.2020.01.004","article-title":"Candida auris candidaemia in an intensive care unit - Prospective observational study to evaluate epidemiology, risk factors, and outcome","volume":"57","author":"Shastri","year":"2020","journal-title":"J. Crit. Care"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3390\/jof6040239","article-title":"Fosmanogepix: A review of the first-in-class broad spectrum agent for the treatment of invasive fungal infections","volume":"6","author":"Shaw","year":"2020","journal-title":"J. Fungi (Basel)"},{"key":"B108","doi-asserted-by":"publisher","first-page":"e1436","DOI":"10.1093\/cid\/ciac735","article-title":"Comparative outcomes of candida auris bloodstream infections: A multicenter retrospective case-control study","volume":"76","author":"Simon","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3390\/jof9010103","article-title":"Protective Efficacy of Anti-Hyr1p Monoclonal Antibody against Systemic Candidiasis Due to Multi-Drug-Resistant Candida auris","volume":"9","author":"Singh","year":"2023","journal-title":"J. Fungi (Basel)"},{"key":"B110","doi-asserted-by":"publisher","first-page":"e1007460","DOI":"10.1371\/journal.ppat.1007460","article-title":"The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection","volume":"15","author":"Singh","year":"2019","journal-title":"PloS Pathog."},{"key":"B111","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","article-title":"Liposomal amphotericin B (AmBisome((R))): A review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions","volume":"76","author":"Stone","year":"2016","journal-title":"Drugs"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.649875","article-title":"Membrane-interacting antifungal peptides","volume":"9","author":"Struyfs","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"e3001762","DOI":"10.1371\/journal.pbio.3001762","article-title":"Niclosamide-loaded nanoparticles disrupt Candida biofilms and protect mice from mucosal candidiasis","volume":"20","author":"Sutar","year":"2022","journal-title":"PloS Biol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1139\/cjm-2024-0248","article-title":"From patterns to prediction: machine learning and antifungal resistance biomarker discovery","volume":"71","author":"Thorn","year":"2025","journal-title":"Can. J. Microbiol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.scib.2020.12.035","article-title":"Berberine reverses multidrug resistance in Candida albicans by hijacking the drug efflux pump Mdr1p","volume":"66","author":"Tong","year":"2021","journal-title":"Sci. Bull. (Beijing)"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e0221522","DOI":"10.1128\/mbio.02215-22","article-title":"Antagonism of the azoles to olorofim and cross-resistance are governed by linked transcriptional networks in aspergillus fumigatus","volume":"13","author":"van Rhijn","year":"2022","journal-title":"mBio"},{"key":"B117","doi-asserted-by":"publisher","first-page":"e0141922","DOI":"10.1128\/aac.01419-22","article-title":"Clinical efficacy and safety of a novel antifungal, fosmanogepix, in patients with candidemia caused by candida auris: results from a phase 2 trial","volume":"67","author":"Vazquez","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01673","article-title":"Silver nanoantibiotics display strong antifungal activity against the emergent multidrug-resistant yeast candida auris under both planktonic and biofilm growing conditions","volume":"11","author":"Vazquez-Munoz","year":"2020","journal-title":"Front. Microbiol."},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1389020","article-title":"Pore-forming peptide C14R exhibits potent antifungal activity against clinical isolates of Candida albicans and Candida auris","volume":"14","author":"Velez","year":"2024","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.ijantimicag.2019.02.015","article-title":"Antibacterial and antifungal properties of resveratrol","volume":"53","author":"Vestergaard","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftaa034","article-title":"Candida auris: a fungus with identity crisis","volume":"78","author":"Vila","year":"2020","journal-title":"Pathog. Dis."},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11041063","article-title":"Antifungal drug resistance: an emergent health threat","volume":"11","author":"Vitiello","year":"2023","journal-title":"Biomedicines"},{"key":"B123","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1128\/AAC.00432-11","article-title":"Discovery of a novel class of orally active antifungal beta-1,3-D-glucan synthase inhibitors","volume":"55","author":"Walker","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B124","doi-asserted-by":"publisher","first-page":"36886","DOI":"10.1039\/d4ra06392a","article-title":"Regulation of oxidative stress enzymes in Candida auris by Dermaseptin: potential implications for antifungal drug discovery","volume":"14","author":"Wani","year":"2024","journal-title":"RSC Adv."},{"key":"B125","doi-asserted-by":"publisher","first-page":"e19199","DOI":"10.7717\/peerj.19199","article-title":"Nanoparticle-based antifungal therapies innovations mechanisms and future prospects","volume":"13","author":"Wu","year":"2025","journal-title":"PeerJ"},{"key":"B126","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12866-024-03334-0","article-title":"Mechanism and bioinformatics analysis of the effect of berberine-enhanced fluconazole against drug-resistant Candida albicans","volume":"24","author":"Wu","year":"2024","journal-title":"BMC Microbiol."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02063-19","article-title":"In vitro antifungal susceptibility of the emerging multidrug-resistant pathogen candida auris to miltefosine alone and in combination with amphotericin B","volume":"64","author":"Wu","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B128","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41541-025-01171-4","article-title":"Protective efficacy of the pan-fungal vaccine NXT-2 against vulvovaginal candidiasis in a murine model","volume":"10","author":"Wychrij","year":"2025","journal-title":"NPJ Vaccines"},{"key":"B129","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/DDDT.S230857","article-title":"In vitro Antifungal Effects of Berberine Against Candida spp. In Planktonic and Biofilm Conditions","volume":"14","author":"Xie","year":"2020","journal-title":"Drug Des. Devel Ther."},{"key":"B130","doi-asserted-by":"publisher","first-page":"e0058422","DOI":"10.1128\/msphere.00584-22","article-title":"Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis","volume":"8","author":"Xin","year":"2023","journal-title":"mSphere"},{"key":"B131","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.phymed.2017.10.018","article-title":"Plant phenolics and terpenoids as adjuvants of antibacterial and antifungal drugs","volume":"37","author":"Zacchino","year":"2017","journal-title":"Phytomedicine"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1641373\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T05:38:12Z","timestamp":1753940292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1641373\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":131,"alternative-id":["10.3389\/fcimb.2025.1641373"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1641373","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"article-number":"1641373"}}